RecruitingNot ApplicableNCT07063732

Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise

The Effect of Ketone Monoester Supplementation and High Altitude on Exercising Cerebral Blood Flow


Sponsor

McMaster University

Enrollment

14 participants

Start Date

May 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this trial is to investigate the effect of acute ketone monoester ingestion (0.6 g KME/kg body weight) on the occurrence of the ventilatory threshold and the subsequent response of blood velocity in cerebral arteries during a maximal exercise test at low altitude and high altitude.


Eligibility

Min Age: 18 YearsMax Age: 35 Years

Inclusion Criteria1

  • \- Must be a member of the research expedition team travelling to the Barcroft Research Station in White Mountain California

Exclusion Criteria6

  • BMI \> 30
  • No prescribed medications (oral contraceptives excluded)
  • History of smoking
  • Currently following a ketogenic diet or consuming exogenous ketogenic supplements
  • History of heart, lung, blood vessel, or kidney disease
  • Currently pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTKetone Monoester (KME)

0.6 g KME per kg body mass; \[R\]-3-hydroxybutyl \[R\]-3-hydroxybutyrate. (Delta G Ketone, TΔS, Oxford).

DIETARY_SUPPLEMENTPlacebo

Inert, calorie-free placebo drink that is taste-matched to the ketone monoester supplement


Locations(2)

Barcroft Research Station

Bishop, California, United States

University of Guelph

Guelph, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07063732


Related Trials